|
NUDT15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85595983026587E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50000012411056E-11 |
| Normal-vs-Stage2 |
7.627400E-04 |
| Normal-vs-Stage3 |
4.82947015711943E-14 |
| Normal-vs-Stage4 |
1.70796710108334E-12 |
| Stage1-vs-Stage2 |
3.542000E-01 |
| Stage1-vs-Stage3 |
7.403900E-03 |
| Stage1-vs-Stage4 |
1.939860E-03 |
| Stage2-vs-Stage3 |
2.504000E-02 |
| Stage2-vs-Stage4 |
5.422500E-03 |
| Stage3-vs-Stage4 |
3.345800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9960036108132E-15 |
| Normal-vs-AfricanAmerican |
2.19459999994953E-06 |
| Normal-vs-Asian |
3.90669999994486E-06 |
| Caucasian-vs-AfricanAmerican |
9.447600E-01 |
| Caucasian-vs-Asian |
3.193400E-01 |
| AfricanAmerican-vs-Asian |
5.451000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-15 |
| Normal-vs-Female |
4.06209510472877E-11 |
| Male-vs-Female |
6.536400E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.1332002003428E-10 |
| Normal-vs-Age(41-60Yrs) |
1.13775655563586E-12 |
| Normal-vs-Age(61-80Yrs) |
2.52640020015349E-10 |
| Normal-vs-Age(81-100Yrs) |
7.435200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.389800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.390200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.993600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.847400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.702600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.438600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.484150E-03 |
| Classical-VS-Follicular |
4.377400E-01 |
| Classical-VS-Other |
5.783600E-01 |
| Classical-VS-Normal |
2.42283970663948E-12 |
| Tall-VS-Follicular |
2.564600E-03 |
| Tall-VS-Other |
4.057200E-01 |
| Tall-VS-Normal |
2.16238138506242E-12 |
| Follicular-VS-Other |
5.134800E-01 |
| Follicular-VS-Normal |
1.13509999999373E-06 |
| Other-VS-Normal |
1.417720E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.90349958018032E-10 |
| Normal-vs-N1 |
1.14309672838431E-11 |
| N0-vs-N1 |
8.164100E-02 |
|
|
